MedTrace Logo

HTEMS Treatment of Diabetic Polyneuropathy

NCT04593992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-07-20

No results posted yet for this study

Summary

So far, there are no sufficient pharmacologic therapies for the treatment of diabetic neuropathy. Therefore, we evaluated application of high-tone external muscle stimulation (HTEMS) compared to placebo treatment in patients with diabetic neuropathy.

Conditions

  • Diabetic Polyneuropathy

Interventions

DEVICE

HTEMS

high-tone external muscle stimulation

DEVICE

Placebo

Placebo stimulation

Sponsors & Collaborators

  • gbo Medizintechnik AG

    collaborator UNKNOWN

  • West German Center of Diabetes and Health

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2021-10-31
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593992 on ClinicalTrials.gov